CareDx raised revenue guidance for the year 2024. The company delivered strong financial and operational performance in the first quarter and is raising guidance for the full year 2024 revenue which is expected to be in the range of $274 million to $282 million from our prior guidance of $260 million to $274 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.53 USD | +7.92% |
|
+10.46% | +29.42% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.42% | 811M | |
-42.89% | 7.8B | |
+6.77% | 3.53B | |
-27.06% | 1.84B | |
-21.23% | 1.66B | |
+9.31% | 951M | |
-12.66% | 670M | |
-26.12% | 533M | |
+1.19% | 297M | |
-26.05% | 142M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx Raises Revenue Guidance for the Year 2024